Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Public ClinicalTrials.gov record NCT00862277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the persistence of bactericidal antibodies in adolescents and adults who received one dose of Menactra® vaccine approximately four to eight years earlier
Study identification
- NCT ID
- NCT00862277
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 763 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 14 Years to 27 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2008 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- Apr 14, 2016
2008 – 2009
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Marietta | Georgia | 30062 | — |
| Not listed | Martinez | Georgia | 30907 | — |
| Not listed | Woodstock | Georgia | 30189 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Austintown | Ohio | 44515 | — |
| Not listed | Cleveland | Ohio | 44121 | — |
| Not listed | Erie | Pennsylvania | 16505 | — |
| Not listed | Greenville | Pennsylvania | 16125 | — |
| Not listed | Harleysville | Pennsylvania | 19438 | — |
| Not listed | Latrobe | Pennsylvania | 15650 | — |
| Not listed | Pittsburgh | Pennsylvania | 15236 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Sellersville | Pennsylvania | 18960 | — |
| Not listed | Wexford | Pennsylvania | 15090 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Spokane | Washington | 99202 | — |
| Not listed | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00862277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00862277 live on ClinicalTrials.gov.